Loading...
Market
Will a new clinical trial investigating dietary interventions for schizophrenia be approved in the US by the end of 2024?
2
Maryland•Health•Spring Grove Hospital Center•Institutional Review Board•IRB•Chris Palmer•Harvard•Herrera Scott
Resolution / Starting Odds
Yes • 50%
No • 50%
ClinicalTrials.gov or official announcements from relevant health departments
Story
Maryland Health Department Shuts Down Ketogenic Diet Study for Schizophrenia at Spring Grove
Jul 14, 2024, 02:01 PM
The Maryland Secretary of Health has shut down a clinical trial investigating the use of a ketogenic diet as a treatment for schizophrenia at Spring Grove Hospital Center. The study, which was privately funded and approved by an Institutional Review Board (IRB), was led by top researchers including Dr. Chris Palmer from Harvard. Dr. Herrera Scott recently shared a letter explaining the decision. The decision has sparked controversy and calls for reversal, as the trial was already well underway and showing promising results. Proponents argue that dietary interventions could offer significant benefits for mental health disorders, with some anecdotal evidence suggesting improvements in conditions such as schizophrenia.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No new competitors • 25%
1 new competitor • 25%
2 new competitors • 25%
3 or more new competitors • 25%
Yes • 50%
No • 50%
None • 25%
One • 25%
Two • 25%
Three or more • 25%
Yes • 50%
No • 50%
Ketogenic Diet • 25%
Carnivore Diet • 25%
Mediterranean Diet • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%